AurimMed Pharma
Pharmaceutical Manufacturing • 
Park City, Utah, United States • 1-10 Employees
Company overview
| Headquarters | P.O. Box 980007, Park City, Utah 84098, US |
| Phone number | +14355130967 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | SMA, Parkinson'S Disease, Analgesics, Anticonvulsant Agents, Neuroprotection |
| Founded | 2007 |
| Employees | 1-10 |
| Socials |
Key Contact at AurimMed Pharma
Michael Cederstrom
Executive Vice President of Legal Affairs
AurimMed Pharma Email Formats
AurimMed Pharma uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@aurimmed.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@aurimmed.com | 100% |
About AurimMed Pharma
AurimMed Pharma is a product-oriented, market-driven, and applied-science development-stage pharmaceutical company. AurimMed is developing small-molecule pharmaceutical products by using carefully selected privileged structures as lead compounds for proprietary product development. This rational, proven strategy greatly shortens product development times while enhancing clinical and commercial success. The company is currently developing compounds active in the Central Nervous System (CNS) such as novel anticonvulsants, analgesics (for neuropathic pain), and neuroprotective agents. Such CNS-active agents are also often useful in the treatment of anxiety, depression, insomnia, schizophrenia, Parkinson’s disease, and bipolar disorder. The initial focus of AurimMed Pharma is the development of safe and effective drug products up through Phase I clinical trials. Upon completion of the initial trials, the Company intends to seek agreements with larger biopharmaceutical and/or large pharmaceutical companies in order to co-develop the products through Phase II/III clinical trials. Alternatively, the company would consider licensing the products to companies with existing marketing and business development infrastructure for the marketing of drug products.
AurimMed Pharma revenue & valuation
| Annual revenue | $10,000,000 |
| Revenue per employee | $3,334,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $32,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
AurimMed Pharma has never raised funding before.
AurimMed Pharma Tech Stack
Discover the technologies and tools that power AurimMed Pharma's digital infrastructure, from frameworks to analytics platforms.
Miscellaneous
JavaScript libraries
CMS
JavaScript libraries
Font scripts
Netherlands
United Kingdom
Australia
Canada
SpainFrequently asked questions
4.8
40,000 users
